Regulation of proteolysis by human deubiquitinating enzymes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 1, 2014, Pages 114-128

  Eletr, Ziad M ^a   Wilkinson, Keith D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deubiquitinating enzyme; Poly ubiquitin; Proteolysis; Regulation; Ubiquitin

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; ATAXIN 3; CYTIDINE DEAMINASE; HISTONE H2A; HISTONE H2B; METALLOPROTEINASE; POLYUBIQUITIN; PROTEIN P53; THIOL PROTEINASE; TRANSCRIPTION FACTOR YY1; UBIQUITIN; UBIQUITIN THIOLESTERASE; UBIQUITINATED PROTEIN;

APOPTOSIS; BACTERIAL INFECTION; BIOINFORMATICS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL FRACTIONATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DEUBIQUITINATION; DNA DAMAGE; DNA REPAIR; DNA RESPONSIVE ELEMENT; DOWN REGULATION; EMBRYONIC STEM CELL; ENDOCYTOSIS; ENZYME ACTIVE SITE; ENZYME REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; HOX GENE; HUMAN; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; MALIGNANT MESOTHELIOMA; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REVIEW; SENESCENCE; SEQUENCE ALIGNMENT; TRANSACTIVATION; UBIQUITINATION; UVEA MELANOMA; X CHROMOSOME INACTIVATION;

EID: 84890190983     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.06.027     Document Type: Review

References (222)

1. Pickart C.M., Eddins M.J. Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 2004, 1695:55-72.
2. Wenzel D.M., Stoll K.E., Klevit R.E. E2s: structurally economical and functionally replete. Biochem. J. 2011, 433:31-42.
3. Schulman B.A., Harper J.W. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 2009, 10:319-331.
4. Wenzel D.M., Lissounov A., Brzovic P.S., Klevit R.E. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 2011, 474:105-108.
5. Kee Y., Huibregtse J.M. Regulation of catalytic activities of HECT ubiquitin ligases. Biochem. Biophys. Res. Commun. 2007, 354:329-333.
6. Deshaies R.J., Joazeiro C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78:399-434.
7. Komander D. The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 2009, 37:937-953.
8. Goldknopf I.L., Busch H. Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:864-868.
9. Wright D.E., Wang C.Y., Kao C.F. Histone ubiquitylation and chromatin dynamics. Front. Biosci. 2012, 17:1051-1078.
10. Clague M.J., Urbe S. Endocytosis: the DUB version. Trends Cell Biol. 2006, 16:551-559.
11. Harhaj E.W., Dixit V.M. Regulation of NF-kappaB by deubiquitinases. Immunol. Rev. 2012, 246:107-124.
12. Panier S., Durocher D. Regulatory ubiquitylation in response to DNA double-strand breaks. DNA Repair (Amst) 2009, 8:436-443.
13. Haglund K., Dikic I. Ubiquitylation and cell signaling. EMBO J. 2005, 24:3353-3359.
14. Fushman D., Wilkinson K.D. Structure and recognition of polyubiquitin chains of different lengths and linkage. F1000 Biol. Rep. 2011, 3:26.
15. Emmerich C.H., Schmukle A.C., Walczak H. The emerging role of linear ubiquitination in cell signaling. Sci. Signal. 2011, 4:re5.
16. Iwai K. Diverse ubiquitin signaling in NF-kappaB activation. Trends Cell Biol. 2012, 22:355-364.
17. van der Veen A.G., Ploegh H.L. Ubiquitin-like proteins. Annu. Rev. Biochem. 2012, 81:323-357.
18. Schulman B.A. Twists and turns in ubiquitin-like protein conjugation cascades. Protein Sci. 2011, 20:1941-1954.
19. Hickey C.M., Wilson N.R., Hochstrasser M. Function and regulation of SUMO proteases. Nat. Rev. Mol. Cell Biol. 2012, 13:755-766.
20. Reyes-Turcu F.E., Ventii K.H., Wilkinson K.D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 2009, 78:363-397.
21. Komander D., Clague M.J., Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
22. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123:773-786.
23. Ye Y., Scheel H., Hofmann K., Komander D. Dissection of USP catalytic domains reveals five common insertion points. Mol. Biosyst. 2009, 5:1797-1808.
24. Johnston S.C., Larsen C.N., Cook W.J., Wilkinson K.D., Hill C.P. Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. EMBO J. 1997, 16:3787-3796.
25. Storer A.C., Menard R. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol. 1994, 244:486-500.
26. Amerik A.Y., Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 2004, 1695:189-207.
27. Lee J.G., Baek K., Soetandyo N., Ye Y. Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells. Nat. Commun. 2013, 4:1568.
28. Kulathu Y., Garcia F.J., Mevissen T.E., Busch M., Arnaudo N., Carroll K.S., Barford D., Komander D. Regulation of A20 and other OTU deubiquitinases by reversible oxidation. Nat. Commun. 2013, 4:1569.
29. Cotto-Rios X.M., Bekes M., Chapman J., Ueberheide B., Huang T.T. Deubiquitinases as a signaling target of oxidative stress. Cell Rep. 2012, 2:1475-1484.
30. Borodovsky A., Ovaa H., Kolli N., Gan-Erdene T., Wilkinson K.D., Ploegh H.L., Kessler B.M. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 2002, 9:1149-1159.
31. Sommer S., Weikart N.D., Linne U., Mootz H.D. Covalent inhibition of SUMO and ubiquitin-specific cysteine proteases by an in situ thiol-alkyne addition. Bioorg. Med. Chem. 2013, 21:2511-2517.
32. Ekkebus R., van Kasteren S.I., Kulathu Y., Scholten A., Berlin I., Geurink P.P., de Jong A., Goerdayal S., Neefjes J., Heck A.J., Komander D., Ovaa H. On terminal alkynes that can react with active-site cysteine nucleophiles in proteases. J. Am. Chem. Soc. 2013, 135:2867-2870.
33. Borodovsky A., Kessler B.M., Casagrande R., Overkleeft H.S., Wilkinson K.D., Ploegh H.L. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J. 2001, 20:5187-5196.
34. Wilkinson K.D., Gan-Erdene T., Kolli N. Derivitization of the C-terminus of ubiquitin and ubiquitin-like proteins using intein chemistry: methods and uses. Methods Enzymol. 2005, 399:37-51.
35. Larsen C.N., Krantz B.A., Wilkinson K.D. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 1998, 37:3358-3368.
36. Misaghi S., Ottosen S., Izrael-Tomasevic A., Arnott D., Lamkanfi M., Lee J., Liu J., O'Rourke K., Dixit V.M., Wilson A.C. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol. Cell. Biol. 2009, 29:2181-2192.
37. Machida Y.J., Machida Y., Vashisht A.A., Wohlschlegel J.A., Dutta A. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J. Biol. Chem. 2009, 284:34179-34188.
38. Lam Y.A., Xu W., DeMartino G.N., Cohen R.E. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 1997, 385:737-740.
39. Zhou Z.R., Zhang Y.H., Liu S., Song A.X., Hu H.Y. Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains. Biochem. J. 2012, 441:143-149.
40. Popp M.W., Artavanis-Tsakonas K., Ploegh H.L. Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations. J. Biol. Chem. 2009, 284:3593-3602.
41. Yao T., Song L., Jin J., Cai Y., Takahashi H., Swanson S.K., Washburn M.P., Florens L., Conaway R.C., Cohen R.E., Conaway J.W. Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex. Mol. Cell 2008, 31:909-917.
42. Yao T., Song L., Xu W., DeMartino G.N., Florens L., Swanson S.K., Washburn M.P., Conaway R.C., Conaway J.W., Cohen R.E. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat. Cell Biol. 2006, 8:994-1002.
43. Qiu X.B., Ouyang S.Y., Li C.J., Miao S., Wang L., Goldberg A.L. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J. 2006, 25:5742-5753.
44. Hamazaki J., Iemura S., Natsume T., Yashiroda H., Tanaka K., Murata S. A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes. EMBO J. 2006, 25:4524-4536.
45. Yu H., Mashtalir N., Daou S., Hammond-Martel I., Ross J., Sui G., Hart G.W., Rauscher F.J., Drobetsky E., Milot E., Shi Y., Affar E.B. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol. Cell. Biol. 2010, 30:5071-5085.
46. Jensen D.E., Proctor M., Marquis S.T., Gardner H.P., Ha S.I., Chodosh L.A., Ishov A.M., Tommerup N., Vissing H., Sekido Y., Minna J., Borodovsky A., Schultz D.C., Wilkinson K.D., Maul G.G., Barlev N., Berger S.L., Prendergast G.C., Rauscher F.J. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998, 16:1097-1112.
47. Nishikawa H., Wu W., Koike A., Kojima R., Gomi H., Fukuda M., Ohta T. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. Cancer Res. 2009, 69:111-119.
48. Reyes-Turcu F.E., Wilkinson K.D. Polyubiquitin binding and disassembly by deubiquitinating enzymes. Chem. Rev. 2009, 109:1495-1508.
49. Hu M., Li P., Li M., Li W., Yao T., Wu J.W., Gu W., Cohen R.E., Shi Y. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002, 111:1041-1054.
50. Avvakumov G.V., Walker J.R., Xue S., Allali-Hassani A., Asinas A., Nair U.B., Fang X., Zuo X., Wang Y.X., Wilkinson K.D., Dhe-Paganon S. Two ZnF-UBP domains in isopeptidase T (USP5). Biochemistry 2012, 51:1188-1198.
51. Hu M., Li P., Song L., Jeffrey P.D., Chenova T.A., Wilkinson K.D., Cohen R.E., Shi Y. Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J. 2005, 24:3747-3756.
52. Makarova K.S., Aravind L., Koonin E.V. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem. Sci. 2000, 25:50-52.
53. Balakirev M.Y., Tcherniuk S.O., Jaquinod M., Chroboczek J. Otubains: a new family of cysteine proteases in the ubiquitin pathway. EMBO Rep. 2003, 4:517-522.
54. Wang T., Yin L., Cooper E.M., Lai M.Y., Dickey S., Pickart C.M., Fushman D., Wilkinson K.D., Cohen R.E., Wolberger C. Evidence for bidentate substrate binding as the basis for the K48 linkage specificity of otubain 1. J. Mol. Biol. 2009, 386:1011-1023.
55. Edelmann M.J., Iphofer A., Akutsu M., Altun M., di Gleria K., Kramer H.B., Fiebiger E., Dhe-Paganon S., Kessler B.M. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem. J. 2009, 418:379-390.
56. Licchesi J.D., Mieszczanek J., Mevissen T.E., Rutherford T.J., Akutsu M., Virdee S., El Oualid F., Chin J.W., Ovaa H., Bienz M., Komander D. An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains. Nat. Struct. Mol. Biol. 2012, 19:62-71.
57. Komander D., Barford D. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem. J. 2008, 409:77-85.
58. Bremm A., Freund S.M., Komander D. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat. Struct. Mol. Biol. 2010, 17:939-947.
59. Nanao M.H., Tcherniuk S.O., Chroboczek J., Dideberg O., Dessen A., Balakirev M.Y. Crystal structure of human otubain 2. EMBO Rep. 2004, 5:783-788.
60. Messick T.E., Russell N.S., Iwata A.J., Sarachan K.L., Shiekhattar R., Shanks J.R., Reyes-Turcu F.E., Wilkinson K.D., Marmorstein R. Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein. J. Biol. Chem. 2008, 283:11038-11049.
61. Lin S.C., Chung J.Y., Lamothe B., Rajashankar K., Lu M., Lo Y.C., Lam A.Y., Darnay B.G., Wu H. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J. Mol. Biol. 2008, 376:526-540.
62. Nakada S., Tai I., Panier S., Al-Hakim A., Iemura S., Juang Y.C., O'Donnell L., Kumakubo A., Munro M., Sicheri F., Gingras A.C., Natsume T., Suda T., Durocher D. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature 2010, 466:941-946.
63. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., Ma A., Koonin E.V., Dixit V.M. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004, 430:694-699.
64. Weeks S.D., Grasty K.C., Hernandez-Cuebas L., Loll P.J. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity. J. Biol. Chem. 2011, 286:4555-4565.
65. Tzvetkov N., Breuer P. Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes. Biol. Chem. 2007, 388:973-978.
66. Winborn B.J., Travis S.M., Todi S.V., Scaglione K.M., Xu P., Williams A.J., Cohen R.E., Peng J., Paulson H.L. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J. Biol. Chem. 2008, 283:26436-26443.
67. Mao Y., Senic-Matuglia F., Di Fiore P.P., Polo S., Hodsdon M.E., De Camilli P. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12700-12705.
68. Berke S.J., Chai Y., Marrs G.L., Wen H., Paulson H.L. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J. Biol. Chem. 2005, 280:32026-32034.
69. Matos C.A., de Macedo-Ribeiro S., Carvalho A.L. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Prog. Neurobiol. 2011, 95:26-48.
70. Scheel H., Tomiuk S., Hofmann K. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum. Mol. Genet. 2003, 12:2845-2852.
71. Burnett B., Li F., Pittman R.N. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 2003, 12:3195-3205.
72. Nicastro G., Menon R.P., Masino L., Knowles P.P., McDonald N.Q., Pastore A. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10493-10498.
73. Maytal-Kivity V., Reis N., Hofmann K., Glickman M.H. MPN+, a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function. BMC Biochem. 2002, 3:28.
74. Tran H.J., Allen M.D., Lowe J., Bycroft M. Structure of the Jab1/MPN domain and its implications for proteasome function. Biochemistry 2003, 42:11460-11465.
75. Yao T., Cohen R.E. A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 2002, 419:403-407.
76. Verma R., Aravind L., Oania R., McDonald W.H., Yates J.R., Koonin E.V., Deshaies R.J. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002, 298:611-615.
77. Ambroggio X.I., Rees D.C., Deshaies R.J. JAMM: a metalloprotease-like zinc site in the proteasome and signalosome. PLoS Biol. 2004, 2:E2.
78. Lipscomb W.N., Strater N. Recent advances in zinc enzymology. Chem. Rev. 1996, 96:2375-2434.
79. Cope G.A., Suh G.S., Aravind L., Schwarz S.E., Zipursky S.L., Koonin E.V., Deshaies R.J. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 2002, 298:608-611.
80. Cooper E.M., Cutcliffe C., Kristiansen T.Z., Pandey A., Pickart C.M., Cohen R.E. K63-specific deubiquitination by two JAMM/MPN+complexes: BRISC-associated Brcc36 and proteasomal Poh1. EMBO J. 2009, 28:621-631.
81. McCullough J., Clague M.J., Urbe S. AMSH is an endosome-associated ubiquitin isopeptidase. J. Cell Biol. 2004, 166:487-492.
82. Sato Y., Yoshikawa A., Yamagata A., Mimura H., Yamashita M., Ookata K., Nureki O., Iwai K., Komada M., Fukai S. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature 2008, 455:358-362.
83. Echalier A., Pan Y., Birol M., Tavernier N., Pintard L., Hoh F., Ebel C., Galophe N., Claret F.X., Dumas C. Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:1273-1278.
84. Davies C.W., Paul L.N., Kim M.I., Das C. Structural and thermodynamic comparison of the catalytic domain of AMSH and AMSH-LP: nearly identical fold but different stability. J. Mol. Biol. 2011, 413:416-429.
85. Tanaka K., Mizushima T., Saeki Y. The proteasome: molecular machinery and pathophysiological roles. Biol. Chem. 2012, 393:217-234.
86. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 2009, 78:477-513.
87. Ventii K.H., Wilkinson K.D. Protein partners of deubiquitinating enzymes. Biochem. J. 2008, 414:161-175.
88. Wei N., Deng X.W. The COP9 signalosome. Annu. Rev. Cell Dev. Biol. 2003, 19:261-286.
89. Enchev R.I., Scott D.C., da Fonseca P.C., Schreiber A., Monda J.K., Schulman B.A., Peter M., Morris E.P. Structural basis for a reciprocal regulation between SCF and CSN. Cell Rep. 2012, 2:616-627.
90. Wei N., Serino G., Deng X.W. The COP9 signalosome: more than a protease. Trends Biochem. Sci. 2008, 33:592-600.
91. Lee M.H., Zhao R., Phan L., Yeung S.C. Roles of COP9 signalosome in cancer. Cell Cycle 2011, 10:3057-3066.
92. Brownell J.E., Sintchak M.D., Gavin J.M., Liao H., Bruzzese F.J., Bump N.J., Soucy T.A., Milhollen M.A., Yang X., Burkhardt A.L., Ma J., Loke H.K., Lingaraj T., Wu D., Hamman K.B., Spelman J.J., Cullis C.A., Langston S.P., Vyskocil S., Sells T.B., Mallender W.D., Visiers I., Li P., Claiborne C.F., Rolfe M., Bolen J.B., Dick L.R. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol. Cell 2010, 37:102-111.
93. Nicholson B., Suresh Kumar K.G. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem. Biophys. 2011, 60:61-68.
94. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 2:594-604.
95. Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer 2003, 3:102-109.
96. Li M., Brooks C.L., Kon N., Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 2004, 13:879-886.
97. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002, 416:648-653.
98. Meulmeester E., Maurice M.M., Boutell C., Teunisse A.F., Ovaa H., Abraham T.E., Dirks R.W., Jochemsen A.G. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 2005, 18:565-576.
99. Li S., Zheng H., Mao A.P., Zhong B., Li Y., Liu Y., Gao Y., Ran Y., Tien P., Shu H.B. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J. Biol. Chem. 2010, 285:4291-4297.
100. Stanisic V., Malovannaya A., Qin J., Lonard D.M., O'Malley B.W. OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity. J. Biol. Chem. 2009, 284:16135-16145.
101. Edelmann M.J., Kramer H.B., Altun M., Kessler B.M. Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion. FEBS J. 2010, 277:2515-2530.
102. Durcan T.M., Kontogiannea M., Bedard N., Wing S.S., Fon E.A. Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme. J. Biol. Chem. 2012, 287:531-541.
103. Sun X.X., Challagundla K.B., Dai M.S. Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. EMBO J. 2012, 31:576-592.
104. Juang Y.C., Landry M.C., Sanches M., Vittal V., Leung C.C., Ceccarelli D.F., Mateo A.R., Pruneda J.N., Mao D.Y., Szilard R.K., Orlicky S., Munro M., Brzovic P.S., Klevit R.E., Sicheri F., Durocher D. OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol. Cell 2012, 45:384-397.
105. Wiener R., Zhang X., Wang T., Wolberger C. The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 2012, 483:618-622.
106. Wiborg O., Pedersen M.S., Wind A., Berglund L.E., Marcker K.A., Vuust J. The human ubiquitin multigene family: some genes contain multiple directly repeated ubiquitin coding sequences. EMBO J. 1985, 4:755-759.
107. Doran J.F., Jackson P., Kynoch P.A., Thompson R.J. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J. Neurochem. 1983, 40:1542-1547.
108. Sekiguchi S., Kwon J., Yoshida E., Hamasaki H., Ichinose S., Hideshima M., Kuraoka M., Takahashi A., Ishii Y., Kyuwa S., Wada K., Yoshikawa Y. Localization of ubiquitin C-terminal hydrolase L1 in mouse ova and its function in the plasma membrane to block polyspermy. Am. J. Pathol. 2006, 169:1722-1729.
109. Wada H., Kito K., Caskey L.S., Yeh E.T., Kamitani T. Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem. Biophys. Res. Commun. 1998, 251:688-692.
110. Saigoh K., Wang Y.L., Suh J.G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 1999, 23:47-51.
111. Lowe J., McDermott H., Landon M., Mayer R.J., Wilkinson K.D. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 1990, 161:153-160.
112. Choi J., Levey A.I., Weintraub S.T., Rees H.D., Gearing M., Chin L.S., Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 2004, 279:13256-13264.
113. Liu Z., Meray R.K., Grammatopoulos T.N., Fredenburg R.A., Cookson M.R., Liu Y., Logan T., Lansbury P.T. Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4635-4640.
114. Dayal S., Sparks A., Jacob J., Allende-Vega N., Lane D.P., Saville M.K. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J. Biol. Chem. 2009, 284:5030-5041.
115. Wilkinson K.D., Tashayev V.L., O'Connor L.B., Larsen C.N., Kasperek E., Pickart C.M. Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. Biochemistry 1995, 34:14535-14546.
116. Falquet L., Paquet N., Frutiger S., Hughes G.J., Hoang-Van K., Jaton J.C. A human de-ubiquitinating enzyme with both isopeptidase and peptidase activities in vitro. FEBS Lett. 1995, 359:73-77.
117. Hadari T., Warms J.V., Rose I.A., Hershko A. A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. J. Biol. Chem. 1992, 267:719-727.
118. Raasi S., Varadan R., Fushman D., Pickart C.M. Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat. Struct. Mol. Biol. 2005, 12:708-714.
119. Reyes-Turcu F.E., Horton J.R., Mullally J.E., Heroux A., Cheng X., Wilkinson K.D. The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 2006, 124:1197-1208.
120. Reyes-Turcu F.E., Shanks J.R., Komander D., Wilkinson K.D. Recognition of polyubiquitin isoforms by the multiple ubiquitin binding modules of isopeptidase T. J. Biol. Chem. 2008, 283:19581-19592.
121. Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Lobrich M., Jeggo P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 2004, 64:2390-2396.
122. Stewart G.S. Solving the RIDDLE of 53BP1 recruitment to sites of damage. Cell Cycle 2009, 8:1532-1538.
123. Wang B., Hurov K., Hofmann K., Elledge S.J. NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control. Genes Dev. 2009, 23:729-739.
124. Feng L., Huang J., Chen J. MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev. 2009, 23:719-728.
125. Shao G., Patterson-Fortin J., Messick T.E., Feng D., Shanbhag N., Wang Y., Greenberg R.A. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev. 2009, 23:740-754.
126. Shao G., Lilli D.R., Patterson-Fortin J., Coleman K.A., Morrissey D.E., Greenberg R.A. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3166-3171.
127. Py B.F., Kim M.S., Vakifahmetoglu-Norberg H., Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol. Cell 2013, 49:331-338.
128. Ma A., Malynn B.A. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat. Rev. Immunol. 2012, 12:774-785.
129. Shembade N., Harhaj N.S., Parvatiyar K., Copeland N.G., Jenkins N.A., Matesic L.E., Harhaj E.W. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 2008, 9:254-262.
130. Shembade N., Ma A., Harhaj E.W. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010, 327:1135-1139.
131. Xia Z.P., Sun L., Chen X., Pineda G., Jiang X., Adhikari A., Zeng W., Chen Z.J. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009, 461:114-119.
132. Lamothe B., Besse A., Campos A.D., Webster W.K., Wu H., Darnay B.G. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J. Biol. Chem. 2007, 282:4102-4112.
133. Bosanac I., Wertz I.E., Pan B., Yu C., Kusam S., Lam C., Phu L., Phung Q., Maurer B., Arnott D., Kirkpatrick D.S., Dixit V.M., Hymowitz S.G. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling. Mol. Cell 2010, 40:548-557.
134. Atanassov B.S., Koutelou E., Dent S.Y. The role of deubiquitinating enzymes in chromatin regulation. FEBS Lett. 2011, 585:2016-2023.
135. Gatti M., Pinato S., Maspero E., Soffientini P., Polo S., Penengo L. A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by RNF168 ubiquitin ligase. Cell Cycle 2012, 11:2538-2544.
136. Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E., Vermeulen W., Marteijn J.A., Sixma T.K. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell 2012, 150:1182-1195.
137. Nicassio F., Corrado N., Vissers J.H., Areces L.B., Bergink S., Marteijn J.A., Geverts B., Houtsmuller A.B., Vermeulen W., Di Fiore P.P., Citterio E. Human USP3 is a chromatin modifier required for S phase progression and genome stability. Curr. Biol. 2007, 17:1972-1977.
138. Urbe S., Liu H., Hayes S.D., Heride C., Rigden D.J., Clague M.J. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions. Mol. Biol. Cell 2012, 23:1095-1103.
139. Nakagawa T., Kajitani T., Togo S., Masuko N., Ohdan H., Hishikawa Y., Koji T., Matsuyama T., Ikura T., Muramatsu M., Ito T. Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation. Genes Dev. 2008, 22:37-49.
140. Zhu P., Zhou W., Wang J., Puc J., Ohgi K.A., Erdjument-Bromage H., Tempst P., Glass C.K., Rosenfeld M.G. A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Mol. Cell 2007, 27:609-621.
141. Zhang X.Y., Pfeiffer H.K., Thorne A.W., McMahon S.B. USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle 2008, 7:1522-1524.
142. Zhao Y., Lang G., Ito S., Bonnet J., Metzger E., Sawatsubashi S., Suzuki E., Le Guezennec X., Stunnenberg H.G., Krasnov A., Georgieva S.G., Schule R., Takeyama K., Kato S., Tora L., Devys D. A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Mol. Cell 2008, 29:92-101.
143. Zhang X.Y., Varthi M., Sykes S.M., Phillips C., Warzecha C., Zhu W., Wyce A., Thorne A.W., Berger S.L., McMahon S.B. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol. Cell 2008, 29:102-111.
144. Fuchs G., Shema E., Vesterman R., Kotler E., Wolchinsky Z., Wilder S., Golomb L., Pribluda A., Zhang F., Haj-Yahya M., Feldmesser E., Brik A., Yu X., Hanna J., Aberdam D., Domany E., Oren M. RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation. Mol. Cell 2012, 46:662-673.
145. Vissers J.H., Nicassio F., van Lohuizen M., Di Fiore P.P., Citterio E. The many faces of ubiquitinated histone H2A: insights from the DUBs. Cell Div. 2008, 3:8.
146. Cao R., Tsukada Y., Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 2005, 20:845-854.
147. Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S., Zhang Y. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004, 431:873-878.
148. Fang J., Chen T., Chadwick B., Li E., Zhang Y. Ring1b-mediated H2A ubiquitination associates with inactive X chromosomes and is involved in initiation of X inactivation. J. Biol. Chem. 2004, 279:52812-52815.
149. Majewski I.J., Ritchie M.E., Phipson B., Corbin J., Pakusch M., Ebert A., Busslinger M., Koseki H., Hu Y., Smyth G.K., Alexander W.S., Hilton D.J., Blewitt M.E. Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells. Blood 2010, 116:731-739.
150. Simon J.A., Kingston R.E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 2009, 10:697-708.
151. Schwartz Y.B., Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat. Rev. Genet. 2007, 8:9-22.
152. Scheuermann J.C., Alonso A.G., Oktaba K., Ly-Hartig N., McGinty R.K., Fraterman S., Wilm M., Muir T.W., Müller J. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 2010, 465:243-247.
153. Maertens G.N., El Messaoudi-Aubert S., Elderkin S., Hiom K., Peters G. Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J. 2010, 29:2553-2565.
154. Joo H.Y., Zhai L., Yang C., Nie S., Erdjument-Bromage H., Tempst P., Chang C., Wang H. Regulation of cell cycle progression and gene expression by H2A deubiquitination. Nature 2007, 449:1068-1072.
155. Abdel-Wahab O., Adli M., LaFave L.M., Gao J., Hricik T., Shih A.H., Pandey S., Patel J.P., Chung Y.R., Koche R., Perna F., Zhao X., Taylor J.E., Park C.Y., Carroll M., Melnick A., Nimer S.D., Jaffe J.D., Aifantis I., Bernstein B.E., Levine R.L. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 2012, 22:180-193.
156. Tyagi S., Chabes A.L., Wysocka J., Herr W. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol. Cell 2007, 27:107-119.
157. Dey A., Seshasayee D., Noubade R., French D.M., Liu J., Chaurushiya M.S., Kirkpatrick D.S., Pham V.C., Lill J.R., Bakalarski C.E., Wu J., Phu L., Katavolos P., LaFave L.M., Abdel-Wahab O., Modrusan Z., Seshagiri S., Dong K., Lin Z., Balazs M., Suriben R., Newton K., Hymowitz S., Garcia-Manero G., Martin F., Levine R.L., Dixit V.M. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science (New York, N.Y.) 2012, 337:1541-1546.
158. Peña-Llopis S., Vega-Rubín-de-Celis S., Liao A., Leng N., Pavía-Jiménez A., Wang S., Yamasaki T., Zhrebker L., Sivanand S., Spence P., Kinch L., Hambuch T., Jain S., Lotan Y., Margulis V., Sagalowsky A.I., Summerour P.B., Kabbani W., Wong S.W., Grishin N., Laurent M., Xie X., Haudenschild C.D., Ross M.T., Bentley D.R., Kapur P., Brugarolas J. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 2012, 44:1-12.
159. Harbour J.W., Onken M.D., Roberson E.D., Duan S., Cao L., Worley L.A., Council M.L., Matatall K.A., Helms C., Bowcock A.M. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (New York, N.Y.) 2010, 330:1410-1413.
160. Wiesner T., Murali R., Fried I., Cerroni L., Busam K., Kutzner H., Bastian B.C. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am. J. Surg. Pathol. 2012, 36:818-830.
161. Bott M., Brevet M., Taylor B.S., Shimizu S., Ito T., Wang L., Creaney J., Lake R.A., Zakowski M.F., Reva B., Sander C., Delsite R., Powell S., Zhou Q., Shen R., Olshen A., Rusch V., Ladanyi M. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat. Genet. 2011, 43:668-672.
162. Wiesner T., Obenauf A.C., Murali R., Fried I., Griewank K.G., Ulz P., Windpassinger C., Wackernagel W., Loy S., Wolf I., Viale A., Lash A.E., Pirun M., Socci N.D., Rütten A., Palmedo G., Abramson D., Offit K., Ott A., Becker J.C., Cerroni L., Kutzner H., Bastian B.C., Speicher M.R. Germline mutations in BAP1 predispose to melanocytic tumors. Nat. Genet. 2011, 43:1018-1021.
163. Testa J.R., Cheung M., Pei J., Below J.E., Tan Y., Sementino E., Cox N.J., Dogan A.U., Pass H.I., Trusa S., Hesdorffer M., Nasu M., Powers A., Rivera Z., Comertpay S., Tanji M., Gaudino G., Yang H., Carbone M. Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 2011, 43:1022-1025.
164. Goldstein A.M. Germline BAP1 mutations and tumor susceptibility. Nat. Genet. 2011, 43:925-926.
165. Abdel-Rahman M.H., Pilarski R., Cebulla C.M., Massengill J.B., Christopher B.N., Boru G., Hovland P., Davidorf F.H. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J. Med. Genet. 2011, 48:856-859.
166. Cai S.Y., Babbitt R.W., Marchesi V.T. A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2828-2833.
167. Johansen K.M., Johansen J. Regulation of chromatin structure by histone H3S10 phosphorylation. Chromosome Res. 2006, 14:393-404.
168. Pai M.T., Tzeng S.R., Kovacs J.J., Keaton M.A., Li S.S., Yao T.P., Zhou P. Solution structure of the Ubp-M BUZ domain, a highly specific protein module that recognizes the C-terminal tail of free ubiquitin. J. Mol. Biol. 2007, 370:290-302.
169. Hard R.L., Liu J., Shen J., Zhou P., Pei D. HDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins. Biochemistry 2010, 49:10737-10746.
170. Sarkari F., Sanchez-Alcaraz T., Wang S., Holowaty M.N., Sheng Y., Frappier L. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog. 2009, 5:e1000624.
171. de Bie P., Zaaroor-Regev D., Ciechanover A. Regulation of the polycomb protein RING1B ubiquitination by USP7. Biochem. Biophys. Res. Commun. 2010, 400:389-395.
172. Wright M.H., Berlin I., Nash P.D. Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination. Cell Biochem. Biophys. 2011, 60:39-46.
173. Morita E., Sandrin V., McCullough J., Katsuyama A., Baci Hamilton I., Sundquist W.I. ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 2011, 9:235-242.
174. Rusten T.E., Filimonenko M., Rodahl L.M., Stenmark H., Simonsen A. ESCRTing autophagic clearance of aggregating proteins. Autophagy 2008, 4.
175. Morita E., Sandrin V., Chung H.Y., Morham S.G., Gygi S.P., Rodesch C.K., Sundquist W.I. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 2007, 26:4215-4227.
176. Grabbe C., Husnjak K., Dikic I. The spatial and temporal organization of ubiquitin networks. Nat. Rev. Mol. Cell Biol. 2011, 12:295-307.
177. Mizuno E., Iura T., Mukai A., Yoshimori T., Kitamura N., Komada M. Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes. Mol. Biol. Cell 2005, 16:5163-5174.
178. Niendorf S., Oksche A., Kisser A., Lohler J., Prinz M., Schorle H., Feller S., Lewitzky M., Horak I., Knobeloch K.P. Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol. Cell. Biol. 2007, 27:5029-5039.
179. Row P.E., Prior I.A., McCullough J., Clague M.J., Urbe S. The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation. J. Biol. Chem. 2006, 281:12618-12624.
180. Mizuno E., Kobayashi K., Yamamoto A., Kitamura N., Komada M. A deubiquitinating enzyme UBPY regulates the level of protein ubiquitination on endosomes. Traffic 2006, 7:1017-1031.
181. Wu X., Yen L., Irwin L., Sweeney C., Carraway K.L. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol. Cell. Biol. 2004, 24:7748-7757.
182. Korolchuk V.I., Menzies F.M., Rubinsztein D.C. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 2010, 584:1393-1398.
183. Kirkin V., McEwan D.G., Novak I., Dikic I. A role for ubiquitin in selective autophagy. Mol. Cell 2009, 34:259-269.
184. Olzmann J.A., Li L., Chin L.S. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr. Med. Chem. 2008, 15:47-60.
185. Swinnen E., Buttner S., Outeiro T.F., Galas M.C., Madeo F., Winderickx J., Franssens V. Aggresome formation and segregation of inclusions influence toxicity of alpha-synuclein and synphilin-1 in yeast. Biochem. Soc. Trans. 2011, 39:1476-1481.
186. Wang H., Ying Z., Wang G. Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains. J. Biol. Chem. 2012, 287:28576-28585.
187. Burnett B.G., Pittman R.N. The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4330-4335.
188. Lee M.J., Lee B.H., Hanna J., King R.W., Finley D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol. Cell. Proteomics 2011, 10. (R110 003871).
189. Koulich E., Li X., DeMartino G.N. Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol. Biol. Cell 2008, 19:1072-1082.
190. Chernova T.A., Allen K.D., Wesoloski L.M., Shanks J.R., Chernoff Y.O., Wilkinson K.D. Pleiotropic effects of Ubp6 loss on drug sensitivities and yeast prion are due to depletion of the free ubiquitin pool. J. Biol. Chem. 2003, 278:52102-52115.
191. Lee B.H., Lee M.J., Park S., Oh D.C., Elsasser S., Chen P.C., Gartner C., Dimova N., Hanna J., Gygi S.P., Wilson S.M., King R.W., Finley D. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 2010, 467:179-184.
192. Rinaldi T., Ricci C., Porro D., Bolotin-Fukuhara M., Frontali L. A mutation in a novel yeast proteasomal gene, RPN11/MPR1, produces a cell cycle arrest, overreplication of nuclear and mitochondrial DNA, and an altered mitochondrial morphology. Mol. Biol. Cell 1998, 9:2917-2931.
193. Piotrowski J., Beal R., Hoffman L., Wilkinson K.D., Cohen R.E., Pickart C.M. Inhibition of the 26S proteasome by polyubiquitin chains synthesized to have defined lengths. J. Biol. Chem. 1997, 272:23712-23721.
194. Leggett D.S., Hanna J., Borodovsky A., Crosas B., Schmidt M., Baker R.T., Walz T., Ploegh H., Finley D. Multiple associated proteins regulate proteasome structure and function. Mol. Cell 2002, 10:495-507.
195. Hanna J., Hathaway N.A., Tone Y., Crosas B., Elsasser S., Kirkpatrick D.S., Leggett D.S., Gygi S.P., King R.W., Finley D. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 2006, 127:99-111.
196. van der Horst A., de Vries-Smits A.M., Brenkman A.B., van Triest M.H., van den Broek N., Colland F., Maurice M.M., Burgering B.M. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 2006, 8:1064-1073.
197. Song M.S., Salmena L., Carracedo A., Egia A., Lo-Coco F., Teruya-Feldstein J., Pandolfi P.P. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 2008, 455:813-817.
198. van der Knaap J.A., Kumar B.R., Moshkin Y.M., Langenberg K., Krijgsveld J., Heck A.J., Karch F., Verrijzer C.P. GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol. Cell 2005, 17:695-707.
199. Faustrup H., Bekker-Jensen S., Bartek J., Lukas J., Mailand N. USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin. J. Cell Biol. 2009, 184:13-19.
200. Ma H., Chen H., Guo X., Wang Z., Sowa M.E., Zheng L., Hu S., Zeng P., Guo R., Diao J., Lan F., Harper J.W., Shi Y.G., Xu Y., Shi Y. M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:4828-4833.
201. Everett R.D., Meredith M., Orr A., Cross A., Kathoria M., Parkinson J. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 1997, 16:566-577.
202. Holowaty M.N., Zeghouf M., Wu H., Tellam J., Athanasopoulos V., Greenblatt J., Frappier L. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 2003, 278:29987-29994.
203. Soares L., Seroogy C., Skrenta H., Anandasabapathy N., Lovelace P., Chung C.D., Engleman E., Fathman C.G. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat. Immunol. 2004, 5:45-54.
204. Pohl C., Jentsch S. Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell 2008, 132:832-845.
205. Hasdemir B., Murphy J.E., Cottrell G.S., Bunnett N.W. Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2. J. Biol. Chem. 2009, 284:28453-28466.
206. Avvakumov G.V., Walker J.R., Xue S., Finerty P.J., Mackenzie F., Newman E.M., Dhe-Paganon S. Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8). J. Biol. Chem. 2006, 281:38061-38070.
207. Ernst A., Avvakumov G., Tong J., Fan Y., Zhao Y., Alberts P., Persaud A., Walker J.R., Neculai A.M., Neculai D., Vorobyov A., Garg P., Beatty L., Chan P.K., Juang Y.C., Landry M.C., Yeh C., Zeqiraj E., Karamboulas K., Allali-Hassani A., Vedadi M., Tyers M., Moffat J., Sicheri F., Pelletier L., Durocher D., Raught B., Rotin D., Yang J., Moran M.F., Dhe-Paganon S., Sidhu S.S. A strategy for modulation of enzymes in the ubiquitin system. Science 2013, 339:590-595.
208. Xu G., Tan X., Wang H., Sun W., Shi Y., Burlingame S., Gu X., Cao G., Zhang T., Qin J., Yang J. Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1. J. Biol. Chem. 2010, 285:969-978.
209. Ye Y., Akutsu M., Reyes-Turcu F., Enchev R.I., Wilkinson K.D., Komander D. Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Rep. 2011, 12:350-357.
210. Das C., Hoang Q.Q., Kreinbring C.A., Luchansky S.J., Meray R.K., Ray S.S., Lansbury P.T., Ringe D., Petsko G.A. Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:4675-4680.
211. Boudreaux D.A., Maiti T.K., Davies C.W., Das C. Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9117-9122.
212. Misaghi S., Galardy P.J., Meester W.J., Ovaa H., Ploegh H.L., Gaudet R. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate. J. Biol. Chem. 2005, 280:1512-1520.
213. Nishio K., Kim S.W., Kawai K., Mizushima T., Yamane T., Hamazaki J., Murata S., Tanaka K., Morimoto Y. Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain. Biochem. Biophys. Res. Commun. 2009, 390:855-860.
214. Burgie S.E., Bingman C.A., Soni A.B., Phillips G.N. Structural characterization of human Uch37. Proteins 2011, 80:649-654.
215. Landreville S., Agapova O.A., Matatall K.A., Kneass Z.T., Onken M.D., Lee R.S., Bowcock A.M., Harbour J.W. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin. Cancer Res. 2012, 18:408-416.
216. Boone D.L., Turer E.E., Lee E.G., Ahmad R.C., Wheeler M.T., Tsui C., Hurley P., Chien M., Chai S., Hitotsumatsu O., McNally E., Pickart C., Ma A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 2004, 5:1052-1060.
217. Duwel M., Welteke V., Oeckinghaus A., Baens M., Kloo B., Ferch U., Darnay B.G., Ruland J., Marynen P., Krappmann D. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J. Immunol. 2009, 182:7718-7728.
218. Wang Q., Li L., Ye Y. Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J. Cell Biol. 2006, 174:963-971.
219. Yoneyama M., Tochio N., Umehara T., Koshiba S., Inoue M., Yabuki T., Aoki M., Seki E., Matsuda T., Watanabe S., Tomo Y., Nishimura Y., Harada T., Terada T., Shirouzu M., Hayashizaki Y., Ohara O., Tanaka A., Kigawa T., Yokoyama S. Structural and functional differences of SWIRM domain subtypes. J. Mol. Biol. 2007, 369:222-238.
220. Beck F., Unverdorben P., Bohn S., Schweitzer A., Pfeifer G., Sakata E., Nickell S., Plitzko J.M., Villa E., Baumeister W., Forster F. Near-atomic resolution structural model of the yeast 26S proteasome. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:14870-14875.
221. Sierra M.I., Wright M.H., Nash P.D. AMSH interacts with ESCRT-0 to regulate the stability and trafficking of CXCR4. J. Biol. Chem. 2010, 285:13990-14004.
222. Lyapina S., Cope G., Shevchenko A., Serino G., Tsuge T., Zhou C., Wolf D.A., Wei N., Deshaies R.J. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 2001, 292:1382-1385.